Education
About Us
Working with TipRanks
Follow Us
SMS Pharmaceuticals Limited (IN:SMSPHARMA)
:SMSPHARMA
RESEARCH TOOLSreports
Total Valuation
SMS Pharmaceuticals Limited has a market cap or net worth of ₹20.50B. The enterprise value is ₹21.55B.
Market Cap₹20.50B
Enterprise Value₹21.55B
Share Statistics
SMS Pharmaceuticals Limited has 88,652,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding88,652,030
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
SMS Pharmaceuticals Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.64%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.64%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee6.54M
Profits Per Employee577.57K
Employee Count1,197
Asset Turnover0.68
Inventory Turnover2.24
Valuation Ratios
The current PE Ratio of SMS Pharmaceuticals Limited is 27.1. SMS Pharmaceuticals Limited’s PEG ratio is ―.
PE Ratio27.1
PS Ratio―
PB Ratio―
Price to Fair Value2.91
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, SMS Pharmaceuticals Limited had revenue of 7.83B and earned 691.36M in profits. Earnings per share was 8.15.
Revenue7.83B
Gross Profit1.45B
Operating Income1.05B
Pretax Income923.38M
Net Income691.36M
EBITDA1.45B
Earnings Per Share (EPS)8.15
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
SMS Pharmaceuticals Limited pays an annual dividend of ₹0.4, resulting in a dividend yield of 0.17%
Dividend Per Share₹0.4
Dividend Yield0.17%
Payout Ratio4.69%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.26
52-Week Price Change-33.76%
50-Day Moving Average236.87
200-Day Moving Average233.49
Relative Strength Index (RSI)41.03
Average Volume (3m)5.23K
Important Dates
SMS Pharmaceuticals Limited upcoming earnings date is Nov 7, 2025, TBA (Confirmed).
Last Earnings DateAug 9, 2025
Next Earnings DateNov 7, 2025
Ex-Dividend DateSep 22, 2025
Financial Position
SMS Pharmaceuticals Limited as a current ratio of 1.71, with Debt / Equity ratio of 48.58%
Current Ratio1.71
Quick Ratio0.83
Debt to Market Cap0.17
Net Debt to EBITDA1.85
Interest Coverage Ratio5.64
Taxes
In the past 12 months, SMS Pharmaceuticals Limited has paid 249.39M in taxes.
Income Tax249.39M
Effective Tax Rate0.27
Enterprise Valuation
SMS Pharmaceuticals Limited EV to EBITDA ratio is 14.66, with an EV/FCF ratio of -36.18.
EV to Sales2.72
EV to EBITDA14.66
EV to Free Cash Flow-36.18
EV to Operating Cash Flow33.00
Balance Sheet
SMS Pharmaceuticals Limited has ₹90.66M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹90.66M billion.
Cash & Marketable Securities₹90.66M
Total Debt₹0.00
Net Cash-₹90.66M
Net Cash Per Share-₹1.02
Tangible Book Value Per Share₹75.39
Margins
Gross margin is 28.38%, with operating margin of 13.37%, and net profit margin of 8.83%.
Gross Margin28.38%
Operating Margin13.37%
Pretax Margin11.80%
Net Profit Margin8.83%
EBITDA Margin18.55%
EBIT Margin14.17%
Analyst Forecast
The average price target for SMS Pharmaceuticals Limited is ₹241.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹241.00
Price Target Upside6.64% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast10.29%
EPS Growth Forecast26.79%